About Insulin

EDITORS

Steven V. Edelman, MD University of California San Diego San Diego, CA Steven V. Edelman, MD is a Professor of Medicine in the Division of Endocrinology and Metabolism at the University of California, San Diego. He also serves as Director of the Diabetes Care Clinic at the Veterans Affairs Medical Center in San Diego. Dr. Edelman received his medical degree from the University of California, Davis. His postgraduate training included a residency in internal medicine at University of California, Los Angeles - San Fernando, a clinical fellowship in diabetes and metabolism at The Joslin Clinic, a fellowship in endocrinology and metabolism at the Lahey Clinic in Burlington, Massachusetts, and a research fellowship in diabetes and metabolism at the University of California, San Diego. Dr. Edelman is certified in internal medicine and metabolism, diabetes, and endocrinology. Dr. Edelman is the Founder and Director of Taking Control of Your Diabetes, a series of educational and motivational conferences and health fairs for people living with diabetes. He serves as a reviewer for several scientific journals. He has written two books and published more than 100 articles and abstracts relating to diabetes care.

Derek LeRoith, MD, PhD Mount Sinai School of Medicine New York, NY Derek LeRoith, MD, PhD, is an endocrinologist and diabetologist, serving on the faculty of the Division of Endocrinology and Diabetes at the Mount Sinai School of Medicine in New York City. Dr. LeRoith received his medical education in Cape Town, South Africa, with senior residency training at The Middlesex Hospital in London, England. He has extensive experience in diabetes research, working for two decades in various positions at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH), based in Bethesda, Maryland. He was a member of the faculty of the University of Cincinnati College of Medicine and implemented several diabetes teaching and clinical programs in the greater Cincinnati, Ohio, region. In addition to his leadership roles (including previous service on the national board of the American Diabetes Association and his work with the Endocrine Fellows Foundation), Dr. LeRoith serves on the editorial boards for several scientific journals and is a consultant for many healthcare organizations and pharmaceutical companies. Dr. LeRoith has published more than 500 original research papers, reviews, and editorials. He has edited several books on diabetes, including medical textbooks.

Editorial Board

Anuj Bhargava, MD, MBA, CDE, FACP, FACE
Endocrinology
Iowa Diabetes and Endocrinology Center
Des Moines, IA

Nancy J.V. Bohannon, MD
Clinical Diabetes
Monteagle Medical Center
San Francisco, CA

Regina Bonnette, MS, RD, LD, CDE, BCADM
Diabetes Education
Nurtur Health
Irving, TX

A. Enrique Caballero, MD
Endocrinology & Metabolism
Joslin Diabetes Center
Boston, MA

Carlos Campos, MD, MPH
Family Medicine/Public Health
Private Practice
New Braunfels, TX

William Cefalu, MD
Internal Medicine/Endocrinology & Metabolism
Louisiana State University
Baton Rouge, LA

Stephen Clement, MD
Endocrinology/Diabetes
Georgetown University Hospital
Washington, DC

Sheri Colberg-Ochs, PhD
Exercise Physiology
Old Dominion University
Norfolk, VA

Thomas Flood, MD
Diabetes
Georgia Center for Diabetes
Atlanta, GA

Vivian Fonseca, MD
Endocrinology
Tulane University Health Sciences Center
New Orleans, LA

James R. Gavin III, MD, PhD
Endocrinology
Emory University School of Medicine
Atlanta, GA

Linda B. Haas, RN, PhC, CDE
Endocrinology
VA Puget Sound Health Care System
Seattle, WA

John W. Hare, MD
Endocrinology & Metabolism
Consultant in Diabetes
Boston, MA

Lawrence Herman, RPA-C, MPA, DFAAPA
Physician Assistant Studies
New York Institute of Technology
Old Westbury, NY

Paul S. Jellinger, MD
Endocrinology/Diabetes
University of Miami School of Medicine
Miami, FL

June Felice Johnson, BS, PharmD, FASHP, CDM-diabetes
Clinical Pharmacy
Drake University
Des Moines, IA

Francine R. Kaufman, MD
Endocrinology & Metabolism
Childrens Hospital Los Angeles
Los Angeles, CA

Sandra Leal, PharmD, CDE
Clinical Pharmacy
El Rio Health Center
Tucson, AZ

Jack L. Leahy, MD
Endocrinology
University of Vermont
Burlington, VT

Scott E. Nelson, MD
Family Medicine
Cleveland Family Medicine
Cleveland, MS

Elliot J. Rayfield, MD
Endocrinology & Diabetes
Mount Sinai School of Medicine
New York, NY

Timothy S. Reid, MD
Family Medicine/Diabetes
Mercy Diabetes Center
Janesville, WI

Susan M. Renda, MS, CRNP, CDE
Primary Care/Diabetes
Clinical Associates
Reisterstown, MD

John G. Ryan, Dr.P.H.
Family Medicine and Community Health
University of Miami Miller School of Medicine
Miami, FL

Charles Shaefer, Jr, MD
Internal Medicine
University Primary Care Physicians
Augusta, GA

Linda Siminerio, PhD, CDE
Diabetes
University of Pittsburgh Medical Center
Pittsburgh, PA

Leonel Villa-Caballero, MD, PhD
Internal Medicine & Metabolism/Public Health/
Cross-Cultural & International Medicine
University of California, San Diego
La Jolla, CA

Aaron I. Vinik, MD, PhD
Endocrinology
Eastern Virginia Medical School
Norfolk, VA

Russell D. White, MD
Family Medicine
University of Missouri
Kansas City, MO
Editors

Acknowledgements

Dr. Anuj Bhargava—Speakers Bureau: Abbott Laboratories, Amylin Pharmaceuticals, Inc., Merck & Co., Inc., Novo Nordisk A/S, Pfizer Inc., sanofi-aventis U.S., Takeda Pharmaceuticals North America, Inc.; Research Support: Amylin, Eli Lilly and Company, Merck, Novo Nordisk, Pfizer.

Dr. Nancy J.V. Bohannon—Consultant, Speaker, Advisory Board Member: Amylin, Eli Lilly, Merck, Novartis Pharmaceuticals, Pfizer, sanofi-aventis, Takeda, VIVUS, Inc.

Ms. Regina Bonnette, MS, RD, LD, CDE, BCADM—Consultant: Medtronic Diabetes.

Dr. Enrique Caballero—Speakers Bureau: Amylin, Eli Lilly, sanofi-aventis, Takeda; Advisory Board: Amylin, Eli Lilly, Pfizer, sanofi-aventis, Takeda.

Dr. Carlos Campos—No financial relationships with commercial interests.

Dr. William Cefalu—Grant Support: Eli Lilly, Merck, Novartis, Pfizer; Advisory Board: Eli Lilly, Merck, Pfizer.

Dr. Stephen Clement—No financial relationships with commercial interests.

Dr. Sheri Colberg-Ochs—No financial relationships with commercial interests.

Dr. Stephen V. Edelman—Medical Advisory Board, Speakers Bureau: Amylin, Animas Corporation, Eli Lilly, Mannkind Corporation, Novo Nordisk, Pfizer, sanofi-aventis.

Dr. Thomas Flood—Honoraria, Speakers Bureau: GlaxoSmithKline, Merck, Pfizer, sanofi-aventis.

Dr. Vivian A. Fonseca—Consulting, Lectures: Daiichi-Sankyo, Eli Lilly, GlaxoSmithKline, Novartis, Novo Nordisk, sanofi-aventis, Takeda; Research Support (to Tulane): American Diabetes Association, AstraZeneca, Daiichi-Sankyo, Eli Lilly,  GlaxoSmithKline, National Institutes of Health, Novartis, Novo Nordisk, Pfizer, sanofi-aventis, Takeda.

Dr. James R. Gavin III—Consultant: Eli Lilly, GlaxoSmithKline, LifeScan, Inc., Merck, Novartis, sanofi-aventis, Takeda; Speakers Bureau: Eli Lilly; Director: Amylin.

Ms. Linda B. Haas—Advisory Board: sanofi-aventis; Stockholder: Amylin.

Dr. John W. Hare—No financial relationships with commercial interests.

Mr. Lawrence Herman—Consultant: Amgen Inc., Eli Lilly, Johnson & Johnson Diabetes Institute.

Dr. Paul S. Jellinger—No financial relationships with commercial interests.

Dr. June Felice Johnson—No financial relationships with commercial interests.

Dr. Francine R. Kaufman—Advisory Board: Abbott, Amylin, Bayer Diabetes, Clinical Products, Inc., DexCom, dLife, Health Maintenance Corporation, Insulet Corporation, Johnson & Johnson, LifeScan, Medtronic Minimed, Inc., Nestlé USA, Novo Nordisk; Grant Support: Johnson & Johnson, LifeScan; Stockholder: Clinical Products, Diabetes Prevention Source.

Dr. Jack L. Leahy—Consultant, Speakers Bureau: Merck, Novo Nordisk, sanofi-aventis.

Dr. Sandra Leal—No financial relationships with commercial interests.

Dr. Derek LeRoith—Consultant, Speakers Bureau: Merck, Novo Nordisk, Pfizer, sanofi-aventis, Takeda.

Dr. Scott E. Nelson—Consultant: sanofi-aventis.

Dr. Elliot J. Rayfield—Speakers Bureau: Amylin, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Novo Nordisk, sanofi-aventis.

Dr. Timothy S. Reid—Speakers Bureau, Advisory Board: Amylin, Bayer AG, GlaxoSmithKline, Medtronic Minimed, Novartis, Novo Nordisk, Pfizer, sanofi-aventis.

Ms. Susan M. Renda—Speaker, Honoraria: Amylin, Bayer, Eli Lilly, sanofi-aventis.

Dr. John G. Ryan—No financial relationships with commercial interests.

Dr. Charles F. Shaefer, Jr.—Speakers Bureau: Daiichi-Sankyo, Takeda; Speaker: Pfizer, sanofi-aventis.

Dr. Linda Siminerio—Advisory Board: Becton, Dickinson and Company, Eli Lilly, General Mills, Novo Nordisk, Takeda; Speaker: Amylin, Merck, sanofi-aventis.

Dr. Leonel Villa-Cabellero—No financial interests with commercial interests.

Dr. Aaron I. Vinik—Consultant, Speakers Bureau: AstraZeneca, Bristol-Myers Squibb Company, dLife, Eli Lilly, Fujisawa Healthcare Inc., GlaxoSmithKline, Health ABC, Medco Health Solutions, Inc., Merck, Mitsubishi Pharma America, Inc., NeurogesX, Neurometrix, Novartis, Paramount Biosciences, LLC, Pfizer, R.W. Johnson Pharmaceutical Research Institute, Regeneron Pharmaceuticals, Inc., sanofi-aventis, Takeda, Theratechnologies, Inc.; Grant Support: American Diabetes Association, ASTA Medica AG, AstraZeneca, Commonwealth Research Board, Dainippon Pharmaceutical Co., Ltd., Dyansys, Inc., Eli Lilly, GMP-Endotherapeutics, Hoechst Marion Roussel, Inc., Juvenile Diabetes Research Foundation International, Lilly Research Laboratories, Mallinckrodt, Inc., Medpace, Inc., Merck, National Institute of Aging, National Institutes of Health, Old Dominion University Research Foundation, Parke-Davis, Pliva d.d., PPD Development, Private Donor Grant, Quintiles Transnational Corporation, Robert Wood Johnson University Hospital, SmithKline Beecham Pharmaceuticals, Takeda, United States Department of Health & Human Services.

Dr. Russell D. White—Speakers Bureau: American Academy of Family Physicians, American Diabetes Association, University of Missouri–Kansas City School of Medicine, The National Procedures Institute; Consultant: Novo Nordisk.